Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | May 01, 2025 08:05am

Gainers

  • NanoVibronix (NASDAQ:NAOV) shares rose 68.2% to $4.81 during Thursday's pre-market session. The market value of their outstanding shares is at $3.9 million.
  • LogicMark (NASDAQ:LGMK) stock moved upwards by 36.2% to $0.02.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock rose 28.98% to $0.89. The market value of their outstanding shares is at $5.8 million.
  • Sera Prognostics (NASDAQ:SERA) stock moved upwards by 11.56% to $3.28. The market value of their outstanding shares is at $123.5 million.
  • Acrivon Therapeutics (NASDAQ:ACRV) shares moved upwards by 10.63% to $1.55. The company's market cap stands at $48.5 million.
  • Conmed (NYSE:CNMD) stock increased by 10.42% to $54.23. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q1 earnings came out yesterday.

Losers

  • Arvinas (NASDAQ:ARVN) stock fell 31.3% to $6.61 during Thursday's pre-market session. The market value of their outstanding shares is at $454.5 million. As per the press release, Q1 earnings came out today.
  • Organon (NYSE:OGN) stock decreased by 16.71% to $10.77. The market value of their outstanding shares is at $2.7 billion. As per the news, the Q1 earnings report came out today.
  • BioCardia (NASDAQ:BCDA) stock decreased by 14.65% to $2.68. The market value of their outstanding shares is at $12.2 million.
  • Psyence Biomedical (NASDAQ:PBM) shares declined by 12.08% to $0.4. The market value of their outstanding shares is at $1.8 million.
  • Amicus Therapeutics (NASDAQ:FOLD) stock decreased by 11.72% to $6.78. The market value of their outstanding shares is at $2.0 billion. The company's, Q1 earnings came out today.
  • Greenwich LifeSciences (NASDAQ:GLSI) stock fell 10.9% to $9.0. The company's market cap stands at $119.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRV ADIL ARVN BCDA CNMD FOLD GLSI LGMK NAOV OGN PBM SERA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist